XLO logo

Xilio Therapeutics, Inc. Common Stock


XLO: Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. Leveraging the GPS platform, they are building a pipeline of tumor-selective cytokine and checkpoint inhibitor immunotherapies to treat cancer. The goal is to overcome the limitations of current I-O therapies by developing products with an improved therapeutic index.


Show XLO Financials

Consumer Interest
SEC Filings

Recent trades of XLO by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by XLO's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of XLO in WallStreetBets Daily Discussion

XLO News

Recent insights relating to XLO

CNBC Recommendations

Recent picks made for XLO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in XLO

Corporate Flights

Flights by private jets registered to XLO